Document is current
Any future updates will be listed below
-
Authors
Barata, Pedro https://orcid.org/0000-0002-8890-2951
Hulsey, Tom https://orcid.org/0009-0002-3985-3177
-
Funding
Funding for this research was provided by:
Johnson and Johnson
- License Information
-
More Information
Article History
First Online: 26 November 2025
Declarations
:
: Pedro Barata: Consultant fees: Astellas, AVEO Oncology, Bayer, BMS, Caris Life Sciences, Dendreon, Eisai, EMD Serono, Guardant Health, Johnson & Johnson, Myovant, Pfizer, and Seattle Genetics. Tom Hulsey: Consultant fees: AstraZeneca, Johnson & Johnson, UT Southwestern.
: This podcast article is based on data presented at the 2025 ASCO Annual Meeting and does not contain any new studies with human participants or animals performed by the authors.
